
Samantha Hawkins
Environmental Reporter at Bloomberg Law
Environmental Reporter for @BLaw // @BYU and @UofMaryland @merrillcollege alum
Articles
-
Jul 31, 2024 |
lexology.com | Theresa C. Carnegie |Rachel Alexander |Madison Castle |Xavier G. Hardy |Stephnie A. John |Alison Peters | +8 more
The PBM regulatory landscape is rapidly evolving at both federal and state levels, making it critical for our clients involved in the PBM space to stay apprised of developments in the industry as they happen. Our team actively monitors these developments to provide you with this PBM Policy and Legislative Update. This update builds on prior issues and highlights federal and state activity from January 2024 through June 2024.
-
Jul 31, 2024 |
lexology.com | Theresa C. Carnegie |Rachel Alexander |Madison Castle |Xavier G. Hardy |Stephnie A. John |Alison Peters | +8 more
The PBM regulatory landscape is rapidly evolving at both federal and state levels, making it critical for our clients involved in the PBM space to stay apprised of developments in the industry as they happen. Our team actively monitors these developments to provide you with this PBM Policy and Legislative Update. This update builds on prior issues and highlights federal and state activity from January 2024 through June 2024.
-
Jul 24, 2024 |
mondaq.com | Tara Dwyer |Lauren M. Moldawer |David Gilboa |Samantha Hawkins
M Mintz More Mintz is a general practice, full-service Am Law 100 law firm with more than 600 attorneys. We are headquartered in Boston and have additional US offices in Los Angeles, Miami, New York City, San Diego, San Francisco, and Washington, DC, as well as an office in Toronto, Canada. The passage of the Inflation Reduction Act of 2022 (IRA) marked a significant milestone in Congress's ongoing efforts to address escalating health care costs.
-
Jul 17, 2024 |
mondaq.com | Samantha Hawkins |Madison Castle
Since our last edition of the Mintz IRA Update, the Medicare Drug Price Negotiation Program (the "Negotiation Program" or "Program") and related maximum fair price (MFP) negotiation process for each of the 10 high-expenditure Medicare Part D drugs selected for negotiation (the "Selected Drugs") has gone into full swing.
-
Jul 16, 2024 |
jdsupra.com | Madison Castle |Samantha Hawkins |Stephnie A. John
Since our last edition of the Mintz IRA Update, the Medicare Drug Price Negotiation Program (the “Negotiation Program” or “Program”) and related maximum fair price (MFP) negotiation process for each of the 10 high-expenditure Medicare Part D drugs selected for negotiation (the “Selected Drugs”) has gone into full swing.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 693
- Tweets
- 376
- DMs Open
- No

RT @environment: “Using the public trust doctrine to modify water rights in the West is a big step for a court to take,” environmental law…

Environmental groups fighting to save the Great Salt Lake have turned to the courts, but their attempt to invoke a legal concept that protects natural resources is being met with skepticism. Read my coverage here: https://t.co/QoWFuUAqXq

RT @bydanielmoore: TODAY: Fourth Circuit vacates West Virginia's water permit for the Mountain Valley Pipeline, throwing another legal wren…